DERMOSCOPY UK LIMITED

Company Registration Number:
05213637 (England and Wales)

Unaudited abridged accounts for the year ended 31 March 2026

Period of accounts

Start date: 01 April 2025

End date: 31 March 2026

DERMOSCOPY UK LIMITED

Contents of the Financial Statements

for the Period Ended 31 March 2026

Balance sheet
Notes

DERMOSCOPY UK LIMITED

Balance sheet

As at 31 March 2026


Notes
2026
2025


£
£
Fixed assets
Investments: 3 480,000 480,000
Total fixed assets: 480,000 480,000
Current assets
Debtors:   24,506 8,036
Cash at bank and in hand: 621,123 348,112
Total current assets: 645,629 356,148
Creditors: amounts falling due within one year:   (165,442) (116,484)
Net current assets (liabilities): 480,187 239,664
Total assets less current liabilities: 960,187 719,664
Total net assets (liabilities): 960,187 719,664
Capital and reserves
Called up share capital: 106 106
Profit and loss account: 960,081 719,558
Shareholders funds: 960,187 719,664

The notes form part of these financial statements

DERMOSCOPY UK LIMITED

Balance sheet statements

For the year ending 31 March 2026 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 27 April 2026
and signed on behalf of the board by:

Name: Dr Jonathan Bowling
Status: Director

The notes form part of these financial statements

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

2. Employees

2026 2025
Average number of employees during the period 3 3

DERMOSCOPY UK LIMITED

Notes to the Financial Statements

for the Period Ended 31 March 2026

3. Fixed investments

The company has invested in dermatology facilities at Welbeck Clinics.